BAY2586116

DRUG3 trials

Sponsors

Bayer, Flinders University

Conditions

Obstructive Sleep ApneaSleep Apnea, Obstructive

Phase 1

A Study to Learn More About How Safe BAY2586116 is, How it Affects the Body, How it Moves Into, Through and Out of the Body at Different Doses in Healthy Japanese Male Participants After Taking Single and Multiple Doses Through the Nose

CompletedNCT04872387

BayerObstructive Sleep Apnea

Start: 2021-05-11End: 2021-08-26Updated: 2023-03-01

BAY2586116 Nasal Spray and OSA Severity

CompletedNCT05527457

Flinders UniversitySleep Apnea, Obstructive

Start: 2022-08-31End: 2022-12-20Updated: 2023-02-15

Phase 2

A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea

CompletedNCT04713826

BayerSleep Apnea, Obstructive

Start: 2021-03-03End: 2021-11-11Updated: 2022-10-26